Copyright Reports & Markets. All rights reserved.

Global Human Prothrombin Complex Market Growth 2019-2024

Request for Sample of this report
Buy now

Table of Contents

    2019-2024 Global Human Prothrombin Complex Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Human Prothrombin Complex Consumption 2014-2024
        • 2.1.2 Human Prothrombin Complex Consumption CAGR by Region
      • 2.2 Human Prothrombin Complex Segment by Type
        • 2.2.1 500 IU/Vial
        • 2.2.2 600 IU/Vial
        • 2.2.3 1000 IU/Vial
        • 2.2.4 Others
      • 2.3 Human Prothrombin Complex Consumption by Type
        • 2.3.1 Global Human Prothrombin Complex Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Human Prothrombin Complex Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Human Prothrombin Complex Sale Price by Type (2014-2019)
      • 2.4 Human Prothrombin Complex Segment by Application
        • 2.4.1 Hemophilia B
        • 2.4.2 Vitamin K Deficiency
        • 2.4.3 Others
      • 2.5 Human Prothrombin Complex Consumption by Application
        • 2.5.1 Global Human Prothrombin Complex Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Human Prothrombin Complex Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Human Prothrombin Complex Sale Price by Application (2014-2019)

      3 Global Human Prothrombin Complex by Players

      • 3.1 Global Human Prothrombin Complex Sales Market Share by Players
        • 3.1.1 Global Human Prothrombin Complex Sales by Players (2017-2019)
        • 3.1.2 Global Human Prothrombin Complex Sales Market Share by Players (2017-2019)
      • 3.2 Global Human Prothrombin Complex Revenue Market Share by Players
        • 3.2.1 Global Human Prothrombin Complex Revenue by Players (2017-2019)
        • 3.2.2 Global Human Prothrombin Complex Revenue Market Share by Players (2017-2019)
      • 3.3 Global Human Prothrombin Complex Sale Price by Players
      • 3.4 Global Human Prothrombin Complex Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Human Prothrombin Complex Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Human Prothrombin Complex Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Human Prothrombin Complex by Regions

      • 4.1 Human Prothrombin Complex by Regions
        • 4.1.1 Global Human Prothrombin Complex Consumption by Regions
        • 4.1.2 Global Human Prothrombin Complex Value by Regions
      • 4.2 Americas Human Prothrombin Complex Consumption Growth
      • 4.3 APAC Human Prothrombin Complex Consumption Growth
      • 4.4 Europe Human Prothrombin Complex Consumption Growth
      • 4.5 Middle East & Africa Human Prothrombin Complex Consumption Growth

      5 Americas

      • 5.1 Americas Human Prothrombin Complex Consumption by Countries
        • 5.1.1 Americas Human Prothrombin Complex Consumption by Countries (2014-2019)
        • 5.1.2 Americas Human Prothrombin Complex Value by Countries (2014-2019)
      • 5.2 Americas Human Prothrombin Complex Consumption by Type
      • 5.3 Americas Human Prothrombin Complex Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Human Prothrombin Complex Consumption by Countries
        • 6.1.1 APAC Human Prothrombin Complex Consumption by Countries (2014-2019)
        • 6.1.2 APAC Human Prothrombin Complex Value by Countries (2014-2019)
      • 6.2 APAC Human Prothrombin Complex Consumption by Type
      • 6.3 APAC Human Prothrombin Complex Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Human Prothrombin Complex by Countries
        • 7.1.1 Europe Human Prothrombin Complex Consumption by Countries (2014-2019)
        • 7.1.2 Europe Human Prothrombin Complex Value by Countries (2014-2019)
      • 7.2 Europe Human Prothrombin Complex Consumption by Type
      • 7.3 Europe Human Prothrombin Complex Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Human Prothrombin Complex by Countries
        • 8.1.1 Middle East & Africa Human Prothrombin Complex Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Human Prothrombin Complex Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Human Prothrombin Complex Consumption by Type
      • 8.3 Middle East & Africa Human Prothrombin Complex Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Human Prothrombin Complex Distributors
      • 10.3 Human Prothrombin Complex Customer

      11 Global Human Prothrombin Complex Market Forecast

      • 11.1 Global Human Prothrombin Complex Consumption Forecast (2019-2024)
      • 11.2 Global Human Prothrombin Complex Forecast by Regions
        • 11.2.1 Global Human Prothrombin Complex Forecast by Regions (2019-2024)
        • 11.2.2 Global Human Prothrombin Complex Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Human Prothrombin Complex Forecast by Type
      • 11.8 Global Human Prothrombin Complex Forecast by Application

      12 Key Players Analysis

      • 12.1 Shire
        • 12.1.1 Company Details
        • 12.1.2 Human Prothrombin Complex Product Offered
        • 12.1.3 Shire Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Shire News
      • 12.2 CSL
        • 12.2.1 Company Details
        • 12.2.2 Human Prothrombin Complex Product Offered
        • 12.2.3 CSL Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 CSL News
      • 12.3 Grifols
        • 12.3.1 Company Details
        • 12.3.2 Human Prothrombin Complex Product Offered
        • 12.3.3 Grifols Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Grifols News
      • 12.4 Octapharma
        • 12.4.1 Company Details
        • 12.4.2 Human Prothrombin Complex Product Offered
        • 12.4.3 Octapharma Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Octapharma News
      • 12.5 Hualan Biological
        • 12.5.1 Company Details
        • 12.5.2 Human Prothrombin Complex Product Offered
        • 12.5.3 Hualan Biological Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Hualan Biological News
      • 12.6 Meheco Xinxing Pharma
        • 12.6.1 Company Details
        • 12.6.2 Human Prothrombin Complex Product Offered
        • 12.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Meheco Xinxing Pharma News

      ...

        13 Research Findings and Conclusion

        Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
        The global average price of Human Prothrombin Complex is in the increasing trend, from 124 USD/Unit in 2013 to 137 USD/Unit in 2017. With the situation of global economy, prices will be in increasing trend in the following five years.
        The classification of Human Prothrombin Complex includes 500 IU/Vial, 600 IU/Vial, 1000 IU/Vial and others, and the proportion of 500 IU/Vial in 2017 is about 51%.
        Human Prothrombin Complex is widely used in Hemophilia B, Vitamin K Deficiency and other diseases. The most proportion of Human Prothrombin Complex is Hemophilia B, and the proportion of sales is 48%.
        North America is the largest consumption place, with a consumption market share nearly 46% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 33%.
        Market competition is not intense. Shire, CSL, Grifols, Octapharma, Hualan Biological, Meheco Xinxing Pharma, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

        According to this study, over the next five years the Human Prothrombin Complex market will register a 11.8% CAGR in terms of revenue, the global market size will reach US$ 1940 million by 2024, from US$ 1000 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Human Prothrombin Complex business, shared in Chapter 3.

        This report presents a comprehensive overview, market shares, and growth opportunities of Human Prothrombin Complex market by product type, application, key manufacturers and key regions and countries.

        This study considers the Human Prothrombin Complex value and volume generated from the sales of the following segments:

        Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
        500 IU/Vial
        600 IU/Vial
        1000 IU/Vial
        Others
        Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
        Hemophilia B
        Vitamin K Deficiency
        Others

        This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
        Americas
        United States
        Canada
        Mexico
        Brazil
        APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
        Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

        The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
        Shire
        CSL
        Grifols
        Octapharma
        Hualan Biological
        Meheco Xinxing Pharma
        ...

        In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

        Research objectives
        To study and analyze the global Human Prothrombin Complex consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
        To understand the structure of Human Prothrombin Complex market by identifying its various subsegments.
        Focuses on the key global Human Prothrombin Complex manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
        To analyze the Human Prothrombin Complex with respect to individual growth trends, future prospects, and their contribution to the total market.
        To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
        To project the consumption of Human Prothrombin Complex submarkets, with respect to key regions (along with their respective key countries).
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
        To strategically profile the key players and comprehensively analyze their growth strategies.

        Buy now